ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

EDEN Eden Research Plc

4.45
0.00 (0.00%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.45 4.30 4.60 4.45 4.45 4.45 287,855 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.60 23.73M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.45p. Over the last year, Eden Research shares have traded in a share price range of 3.675p to 10.25p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £23.73 million. Eden Research has a price to earnings ratio (PE ratio) of -10.60.

Eden Research Share Discussion Threads

Showing 16501 to 16522 of 18300 messages
Chat Pages: Latest  672  671  670  669  668  667  666  665  664  663  662  661  Older
DateSubjectAuthorDiscuss
20/12/2023
08:46
I think they're taking the prices from AQSE Bid 5.50 offer 6.30 now Bid 6p offer 6.30.
I like it better when the share price goes up more slowly, more chance of the share price staying up.
Get fewer day traders.

monet
20/12/2023
08:37
The Stop and Reverse signal I used clicked onto buy yesterday . It's not unerringly accurate but overall it's fine.
alchemy
20/12/2023
08:18
What a wide spread.Good morning folks.So great to have some news on a Monday near a holiday that reinforced the picture the informed prople on hear had modelled. Great relief in my case have perhaps " overdone it".
alchemy
20/12/2023
06:22
Stop changing the subject and trying to wriggle out of your wager that you have spectacularly lost.

You have no idea how many shares I have, but I assure you I am happy to hold everyone one I do. Now pay up loser.

kittybiscuits
19/12/2023
18:34
How convenient… now man up and pay up. I’ll donate my winnings to a charity of your choosing as long as it supports the causes I suggested earlier.
kittybiscuits
19/12/2023
18:22
One closing trade .Does not an exodus make
alchemy
19/12/2023
17:30
WTF are you rabbiting about, ijjit liar?

BTW, I prefer your "investingisatrickygame" avatar.

Now FOAD.

Note the exodus has begun - or did you miss the closing trades?

;D

neutralpov
19/12/2023
17:03
Funny how you want to argue with anyone and everyone, but now that you have lost your bet you conveniently seem to ignore my posts.

Now since I laughing heard from another poster you are a multi millionaire you won’t mind honouring YOUR wager that YOU lost.

kittybiscuits
19/12/2023
15:23
Why is this garbage stock up
wewillwin20
19/12/2023
15:09
erinvale1 19 Dec '23 - 13:58 - 16086
> Eden has been touting its sales and distribution partnerships for over 20 years, yet sales remain minimal.

Naturellement.

Hint: Its very name tells you what it is.

A RESEARCH company.

*N*O*T* a SALES company.

Or hadn't you noticed??

Full marks for honesty to Eden Research plc.

Which is why the fatcat directors themselves, on obscene amounts of remuneration, have invested jackshyte in the shares of this company. They're in the best position, after all, to assess its prospects. ;-)

A Tool (evidently an idiot) of a PI has put nearly ten times more money into the shares of this RESEARCH company than the directors themselves!!! Hahahahahahahahaha!!!! ;D ;D

The far wiser directors, by contrast, put their money, ""earned"" from EDEN.L, into SALES companies.

;-)

Were this actually investable, there wouldn't be a need to "utilise" the "services" of half a dozen ramping outfits, in addition that it is to the services of its presumably mentally ill backers, trapped bulls.

(End of lesson, back to the real world. Let's observe how many use this short-lived spike as the opportunity to man up, swallow their losses and quietly exit....)

neutralpov
19/12/2023
14:22
Well groomed gentleman discusses sustainably chemistry with sparkly city bird.
supersonico
19/12/2023
14:10
Good to see some disgruntled concern trolls returning to the BB.

I was becoming concerned by the lack of posts from that quarter.

weyweyumfozo
19/12/2023
14:01
Neuts, you've been called out for 25K...
timbo_slice
19/12/2023
13:58
Eden has been touting its sales and distribution partnerships for over 20 years, yet sales remain minimal. This company tells us annually that the past year has been transformative’;, which is invariably PR guff. In the wine sector, which is my field and in which I know many top producers, Eden is not on their radar despite the significant worldwide size of the potential market. This company is on the path to “Net Zero”. Shareholders beware!
erinvale1
19/12/2023
13:55
HILARIOUS!!!! ;D ;D

Another engineered spike, like the preceding 21p and 13p ones, but this time barely made it to 6p on ultrathin volumes.....

.... enough to get the desperate maroons salivating though.

Anyone holds out hope for humankind will not be encouraged by the level of crass gullibility and stupidity illustrated in this boiler room DB.

(rotfl)

neutralpov
19/12/2023
13:31
Of course you understand Kenmitch, as farmers have neither the seed nor the means of treating enough seed for 1,427,660 acres of maize (last years Italian acreage) most of the livestock in Italy will have to be slaughtered. What a pity what a shame.
countess point1
19/12/2023
12:35
Kenmitch

Mevalone and Cedroz entered competitive markets, were new unknown products, one whose application was weather affected and a limited label, the other which had production issues (now resolved)

Ecovelex is entering a zero competition market which is the point countess point1 is making. In effect, for a period, they will operate a monopoly.

The landscape is totally different today to say, 3+ years ago. More money, a more mature company, their own R & D to manage and expedite in-house trials. Corteva as a partner with a commercial product for sale.

As the label expands on Mevalone, for example, France and downy and powdery mildew, then weather affecting sales will dissipate, so product sales will become more consistent.10* Eden say's.

With Cedroz production issues resolved, a more comprehensive sales revenue will be received.

Ecovelex we've covered

AND, shortly, an insecticide to be added.

Oh and did Corteva say they are trialling Sunflower crops too? Yes they did!


As I have said before, if my opinion, Eden is a product development company and that is one that is now transitioning, as with Corteva, into a 'partnering' product development company. Thus, there is an automatic demand for the product on approval from the distributor. Eden is not a sales company. The distributors are.

By all means challenge that opinion, but that is how I see Eden.

investingisatrickygame
19/12/2023
11:58
countess point1.

I certainly DO understand. EDEN SHOULD be able to get substantial Ecovelex sales. BUT the same applied to their other products and regulatory approvals for them and they never came. I agree that this time with ECOVELEX there is a higher chance it will be different this time, but going by their dismal sales record to date there’s no certainty.

kenmitch
19/12/2023
10:56
Looks like I won NPOV’s wager. He owes me £25k.

I would like you to donate the money to a charity that supports the families or survivors of suicides. Please post some evidence once you have deposited the money.

kittybiscuits
19/12/2023
10:27
Share price helped by this in The Times Market Report today:-

“Eden was among the highest movers on AIM with its share price increasing by 0.75p or 18.3% to 4.75p after Italian Regulators gave Ecovelex, its seed treatment product, temporary approval for use as a bird repelling seed treatment in corn.”

kenmitch
19/12/2023
10:00
Thanks Ken. At a certain level - and last time at 3p!!) I saw asymmetric opportunity. This time in at 4p, but with funding for >24 months while we test the strength of investing's narrative of BE by YE 24.
I see further rises as newsflow comes in, but who knows how soon that will turn into sales.
For now, happy to be in while this phase unfolds.

brucie5
19/12/2023
09:40
You shouldn't be talking 'spikes' unless you can predict peak price and point of decline.

Ecovelex is one of the game-changers for Eden. There is two more to come shortly. This could be the start of a consistent rise.

investingisatrickygame
Chat Pages: Latest  672  671  670  669  668  667  666  665  664  663  662  661  Older

Your Recent History

Delayed Upgrade Clock